Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
May 2015

Intranasal Ketamine for MDD
An intranasal application of ketamine could be an easier and more practical means to deliver this rapid-acting agent for patients with major depressive disorder.

Smoking and Erectile Dysfunction
A meta-analysis found a positive dose-response association between both the quantity and duration of smoking and the risk that a patient developed erectile dysfunction.

Statins and Depression Risk
Results from a study of statin use in patients with depression support other evidence that this widely used class of drugs may protect brain health.

A Single Elevated Lithium Level Can Impact Renal Function
In almost 700 lithium-treated patients, a single lithium level greater than 1.0 mmol/L was associated with a significant decrease in estimated glomerular filtration rate (eGFR) for at 3 months.

In Brief
FDA Cautions Against Using Testosterone Products for Low Testosterone Levels Due to Aging; Weight Loss Supplement Contains Hidden Fluoxetine

Antipsychotics in PTSD
Many veterans are treated off-label with antipsychotics for post-traumatic stress disorder (PTSD) despite a lack of evidence for their efficacy.

Log in to your account

* denotes required fields.

Trouble logging in?